Several studies have demonstrated that elevated big ET-1 is a risk factor for adverse outcomes in patients with heart failure (12), CAD (13–16), AF (17), and hypertrophic cardiomyopathy (18). The gene discussed is EDN1; the disease is hypertrophic cardiomyopathy.